IT1200217B - Membrana per uso farmaceutico ed industriale - Google Patents

Membrana per uso farmaceutico ed industriale

Info

Publication number
IT1200217B
IT1200217B IT03530/86A IT353086A IT1200217B IT 1200217 B IT1200217 B IT 1200217B IT 03530/86 A IT03530/86 A IT 03530/86A IT 353086 A IT353086 A IT 353086A IT 1200217 B IT1200217 B IT 1200217B
Authority
IT
Italy
Prior art keywords
pharmaceutical
membrane
industrial use
lipophilic substance
polyvinylacetophtalate
Prior art date
Application number
IT03530/86A
Other languages
English (en)
Other versions
IT8603530A0 (it
Original Assignee
Valducci Roberto
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Valducci Roberto filed Critical Valducci Roberto
Publication of IT8603530A0 publication Critical patent/IT8603530A0/it
Priority to IT03530/86A priority Critical patent/IT1200217B/it
Priority to KR1019880700584A priority patent/KR940008415B1/ko
Priority to ES87830347T priority patent/ES2056837T3/es
Priority to PT85819A priority patent/PT85819B/pt
Priority to HU875182A priority patent/HU201684B/hu
Priority to EP87830347A priority patent/EP0263083B1/en
Priority to AT87830347T priority patent/ATE90871T1/de
Priority to US07/194,992 priority patent/US5149542A/en
Priority to CA000548182A priority patent/CA1313132C/en
Priority to PCT/IT1987/000085 priority patent/WO1988002253A1/en
Priority to ZA877316A priority patent/ZA877316B/xx
Priority to DE87830347T priority patent/DE3786316T2/de
Priority to JP62505864A priority patent/JP2518882B2/ja
Priority to AU80259/87A priority patent/AU602931B2/en
Priority to CN87107792A priority patent/CN1062444C/zh
Priority to NZ221987A priority patent/NZ221987A/xx
Priority to DK198802463A priority patent/DK174949B1/da
Priority to KR1019880700584A priority patent/KR880701542A/ko
Priority to SU884355966A priority patent/RU2025122C1/ru
Priority to NO882363A priority patent/NO882363D0/no
Priority to FI882524A priority patent/FI882524L/fi
Application granted granted Critical
Publication of IT1200217B publication Critical patent/IT1200217B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Pens And Brushes (AREA)
  • External Artificial Organs (AREA)
  • Laminated Bodies (AREA)
  • Prostheses (AREA)
  • Paints Or Removers (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Color Television Systems (AREA)
  • Inks, Pencil-Leads, Or Crayons (AREA)
  • Silicon Polymers (AREA)
  • Cosmetics (AREA)
IT03530/86A 1986-09-30 1986-09-30 Membrana per uso farmaceutico ed industriale IT1200217B (it)

Priority Applications (21)

Application Number Priority Date Filing Date Title
IT03530/86A IT1200217B (it) 1986-09-30 1986-09-30 Membrana per uso farmaceutico ed industriale
KR1019880700584A KR940008415B1 (ko) 1986-09-30 1987-09-27 코팅 막과 그로부터 제조된 조성물
ZA877316A ZA877316B (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
AU80259/87A AU602931B2 (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
HU875182A HU201684B (en) 1986-09-30 1987-09-29 Process for producing oral pharmaceutical compositions with controlled releasing active components
EP87830347A EP0263083B1 (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
AT87830347T ATE90871T1 (de) 1986-09-30 1987-09-29 Ueberzugsmembran und damit hergestellte mittel.
US07/194,992 US5149542A (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
CA000548182A CA1313132C (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
PCT/IT1987/000085 WO1988002253A1 (en) 1986-09-30 1987-09-29 Coating membrane and compositions prepared therefrom
ES87830347T ES2056837T3 (es) 1986-09-30 1987-09-29 Procedimiento para preparar una composicion oral farmaceutica de liberacion controlada.
DE87830347T DE3786316T2 (de) 1986-09-30 1987-09-29 Überzugsmembran und damit hergestellte Mittel.
JP62505864A JP2518882B2 (ja) 1986-09-30 1987-09-29 被覆膜及びそれから調製された組成物
PT85819A PT85819B (pt) 1986-09-30 1987-09-29 Processo para a preparacao de membranas de revestimento e de composicoes farmaceuticas obtidas a partir delas
CN87107792A CN1062444C (zh) 1986-09-30 1987-09-30 制备口服受控缓释组合物的方法
NZ221987A NZ221987A (en) 1986-09-30 1987-09-30 A pharmaceutical oral controlled release coated composition wherein the coating membrane comprises a stearic acid and ethylcellulose or a paraffin and methacrylic acid copolymer
DK198802463A DK174949B1 (da) 1986-09-30 1988-05-06 Formuleringer med forlænget frigivelse og deres fremstilling
KR1019880700584A KR880701542A (ko) 1986-09-30 1988-05-26 코팅 막과 그로부터 조제된 조성물
SU884355966A RU2025122C1 (ru) 1986-09-30 1988-05-27 Состав с регулируемым выделением активного вещества
NO882363A NO882363D0 (no) 1986-09-30 1988-05-27 Overtrekks-membran, samt blandinger fremstilt med denne.
FI882524A FI882524L (fi) 1986-09-30 1988-05-27 Belaeggningsmembran och produkter framstaellda av detsamma.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT03530/86A IT1200217B (it) 1986-09-30 1986-09-30 Membrana per uso farmaceutico ed industriale

Publications (2)

Publication Number Publication Date
IT8603530A0 IT8603530A0 (it) 1986-09-30
IT1200217B true IT1200217B (it) 1989-01-05

Family

ID=11109126

Family Applications (1)

Application Number Title Priority Date Filing Date
IT03530/86A IT1200217B (it) 1986-09-30 1986-09-30 Membrana per uso farmaceutico ed industriale

Country Status (18)

Country Link
US (1) US5149542A (it)
EP (1) EP0263083B1 (it)
JP (1) JP2518882B2 (it)
KR (1) KR880701542A (it)
CN (1) CN1062444C (it)
AT (1) ATE90871T1 (it)
AU (1) AU602931B2 (it)
CA (1) CA1313132C (it)
DE (1) DE3786316T2 (it)
DK (1) DK174949B1 (it)
ES (1) ES2056837T3 (it)
FI (1) FI882524L (it)
HU (1) HU201684B (it)
IT (1) IT1200217B (it)
NZ (1) NZ221987A (it)
PT (1) PT85819B (it)
WO (1) WO1988002253A1 (it)
ZA (1) ZA877316B (it)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2581541B1 (fr) * 1985-05-09 1988-05-20 Rhone Poulenc Sante Nouvelles compositions pharmaceutiques permettant la liberation prolongee d'un principe actif et leur procede de preparation
IT1197316B (it) * 1986-10-01 1988-11-30 Proter Spa Formulazione galenica ad uso orale di derivati della reina a lento rilascio per impiego terapeutico
US4894231A (en) * 1987-07-28 1990-01-16 Biomeasure, Inc. Therapeutic agent delivery system
DE3737741A1 (de) * 1987-11-06 1989-05-18 Goedecke Ag Oral anzuwendende arzneiform zur einmal taeglichen behandlung der hypertonie mit diltiazemhydrochlorid
DE3922167A1 (de) * 1988-04-16 1991-01-17 Sanol Arznei Schwarz Gmbh Oral zu verabreichende diltiazemhydrochlorid enthaltende pharmazeutische zubereitung zur einmal taeglichen applikation und verfahren zu deren herstellung
US5344657A (en) * 1988-04-27 1994-09-06 Elf Sanofi Microbeads of diltiazem, a process for their manufacture and a substained-release pharmaceutical composition containing them
DE3822095A1 (de) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab Neue arzneimittelformulierung sowie verfahren zu deren herstellung
IT1226940B (it) * 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US4956182A (en) * 1989-03-16 1990-09-11 Bristol-Myers Company Direct compression cholestyramine tablet and solvent-free coating therefor
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
US4966770A (en) * 1989-07-26 1990-10-30 Himedics, Inc. Prednisone microencapsulated granules
WO1992001446A1 (en) * 1990-07-20 1992-02-06 Aps Research Limited Sustained-release formulations
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation
ZA923474B (en) * 1991-05-20 1993-01-27 Marion Merrell Dow Inc Diltiazem formulation
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
GB2258613B (en) * 1991-08-12 1996-01-10 Euro Celtique Sa Pharmaceutical diltiazem formulation
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
WO1993017673A1 (en) * 1992-03-03 1993-09-16 Top Gold Pty., Limited Sustained release analgesics
DE4313726A1 (de) * 1993-04-27 1994-11-03 Byk Nederland Bv Feste Darreichungsform
US5834024A (en) * 1995-01-05 1998-11-10 Fh Faulding & Co. Limited Controlled absorption diltiazem pharmaceutical formulation
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
PT841062E (pt) * 1995-07-21 2005-03-31 Daiichi Seiyaku Co Processo para a producao de uma preparacao granular
FR2742660B1 (fr) 1995-12-22 1998-04-03 Ethypharm Lab Prod Ethiques Nouvelles formes de microgranules a liberation prolongee contenant du diltiazem comme principe actif
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US5830503A (en) * 1996-06-21 1998-11-03 Andrx Pharmaceuticals, Inc. Enteric coated diltiazem once-a-day formulation
AU722289B2 (en) * 1996-10-01 2000-07-27 Aptalis Pharmatech, Inc. Taste-masked microcapsule compositions and methods of manufacture
KR100522248B1 (ko) * 1997-05-29 2006-02-01 동아제약주식회사 이중제어방출막구조의경구서방성제제및그제조방법
US6004582A (en) * 1997-05-30 1999-12-21 Laboratorios Phoenix U.S.A, Inc. Multi-layered osmotic device
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US6524620B2 (en) 1998-07-20 2003-02-25 Andrx Pharmaceuticals, Inc. Diltiazem controlled release formulation and method of manufacture
WO2000022909A2 (en) * 1998-10-19 2000-04-27 Biotech Australia Pty. Limited Systems for oral delivery
AU6228799A (en) 1998-10-26 2000-05-15 Tanabe Seiyaku Co., Ltd. Sustained-release particles
JP2000198747A (ja) * 1998-10-26 2000-07-18 Tanabe Seiyaku Co Ltd 徐放性粒子
FR2795962B1 (fr) * 1999-07-08 2003-05-09 Prographarm Laboratoires Procede de fabrication de granules enrobes a gout masque et liberation immediate du principe actif
US20060153914A1 (en) * 1999-12-10 2006-07-13 Biovail Laboratories International S.R.L. Chronotherapeutic diltiazem formulations and the administration thereof
US7108866B1 (en) 1999-12-10 2006-09-19 Biovall Laboratories International Srl Chronotherapeutic diltiazem formulations and the administration thereof
US6635277B2 (en) 2000-04-12 2003-10-21 Wockhardt Limited Composition for pulsatile delivery of diltiazem and process of manufacture
WO2001080826A2 (en) 2000-04-20 2001-11-01 Bristol-Myers Squibb Company Taste masking coating composition
IL136899A0 (en) * 2000-06-20 2001-06-14 Caretec Ltd Microcapsules containing arginine and the different uses thereof
KR100411195B1 (ko) * 2000-09-26 2003-12-18 한국화학연구원 케토롤락 트로메타민이 함유된 서방형 펠렛
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8101209B2 (en) 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US6592901B2 (en) * 2001-10-15 2003-07-15 Hercules Incorporated Highly compressible ethylcellulose for tableting
CN100553625C (zh) 2002-04-09 2009-10-28 弗拉梅技术公司 活性成分微囊的口服混悬液
JP4698950B2 (ja) 2002-04-09 2011-06-08 フラメル・テクノロジー アモキシシリンの改変された放出のための、マイクロカプセルの水性懸濁液形態での経口医薬品製剤
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US8420115B2 (en) 2004-06-03 2013-04-16 Taisho Pharmaceutical Co., Ltd. Oral preparations and process for production thereof
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ589750A (en) 2004-10-21 2012-07-27 Aptalis Pharmatech Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
EP2471517A3 (en) 2007-09-14 2012-12-26 Wockhardt Limited Rhein or diacerein compositions
US20100285114A1 (en) * 2007-09-27 2010-11-11 Rahul Dabre Pharmaceutical compositions of rhein or diacerein
PL2207532T3 (pl) 2007-09-27 2013-01-31 Wockhardt Ltd Kompozycja farmaceutyczna reiny lub diacereiny
SG10201407965XA (en) 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
CA2936746C (en) * 2014-10-31 2017-06-27 Purdue Pharma Methods and compositions particularly for treatment of attention deficit disorder
CN115192553A (zh) * 2022-07-29 2022-10-18 山东齐都药业有限公司 单硝酸异山梨酯口溶膜制剂及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB595444A (en) * 1945-07-09 1947-12-04 Gwilym Lloyd Thomas Improvements in or relating to medicaments, and to the preparation thereof
CH283585A (de) * 1950-03-15 1952-06-15 Hoffmann La Roche Zur Herstellung von Tablettenüberzügen geeignetes Gemisch.
US2828206A (en) * 1954-02-24 1958-03-25 Roseuberg Adolf Stabilized fat-soluble vitamins and methods of making same
US2918411A (en) * 1957-11-01 1959-12-22 Olin Mathieson Pharmaceutical preparations
NL122039C (it) * 1960-10-20
US3078216A (en) * 1961-04-11 1963-02-19 American Cyanamid Co Prolonged release oral pharmaceutical preparations
FR1329120A (fr) * 1961-06-13 1963-06-07 Abbott Lab Comprimés revêtus d'un revêtement plastique mince, compositions de revêtement pour comprimés et méthode de revêtement des comprimés
BE644643A (it) * 1963-03-04 1964-09-03
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
US3492397A (en) * 1967-04-07 1970-01-27 Warner Lambert Pharmaceutical Sustained release dosage in the pellet form and process thereof
GB1413186A (en) * 1973-06-27 1975-11-12 Toyo Jozo Kk Process for encapsulation of medicaments
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
BE838505A (fr) * 1976-02-12 1976-05-28 Utilisation de l'uree de granules enrobes de soufre comme source d'azote non proteique pour les ruminants
DK151608C (da) * 1982-08-13 1988-06-20 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PH18946A (en) * 1983-04-21 1985-11-14 Elan Corp Plc Controlled absorption pharmaceutical composition

Also Published As

Publication number Publication date
FI882524A7 (fi) 1988-05-27
CN1062444C (zh) 2001-02-28
ATE90871T1 (de) 1993-07-15
AU602931B2 (en) 1990-11-01
EP0263083B1 (en) 1993-06-23
CA1313132C (en) 1993-01-26
IT8603530A0 (it) 1986-09-30
DE3786316T2 (de) 1993-10-28
EP0263083A1 (en) 1988-04-06
KR880701542A (ko) 1988-11-03
ES2056837T3 (es) 1994-10-16
DK246388D0 (da) 1988-05-06
AU8025987A (en) 1988-04-21
CN87107792A (zh) 1988-06-29
DK246388A (da) 1988-05-26
JPH01500998A (ja) 1989-04-06
HUT49815A (en) 1989-11-28
FI882524A0 (fi) 1988-05-27
ZA877316B (en) 1988-06-29
PT85819B (pt) 1990-08-31
NZ221987A (en) 1990-07-26
PT85819A (en) 1987-10-01
HU201684B (en) 1990-12-28
JP2518882B2 (ja) 1996-07-31
US5149542A (en) 1992-09-22
DK174949B1 (da) 2004-03-22
DE3786316D1 (de) 1993-07-29
WO1988002253A1 (en) 1988-04-07
FI882524L (fi) 1988-05-27

Similar Documents

Publication Publication Date Title
IT1200217B (it) Membrana per uso farmaceutico ed industriale
KR900007837A (ko) 퀴누클리딘, 약제로서 이의 용도 및 이의 제조방법
ES2036199T3 (es) Procedimiento de obtencion de un preparado farmaceutico administrable a traves de una membrana corporal.
ATA214488A (de) Dosierungsform zur schnellen abgabe eines wirkstoffes gefolgt von einer langsamen abgabe eines wirkstoffes
DZ1067A1 (fr) Nouvelles préparations pharmaceutiques à emission prolongée.
DE3486409D1 (de) Zusammensetzung zur kontrollierten Abgabe eines Wirkstoffs.
YU89891A (sh) SMEŠE TGF-beta
ATE10626T1 (de) N-substituierte omega-(2-oxo-imidazolin-1-yl)alkans[uren, deren salze und ester, verfahren zu deren herstellung und diese aktiven substanzen enthaltende pharmazeutische zubereitungen.
DE3783356D1 (de) Benzimidazolderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ATE95070T1 (de) Pharmazeutische zusammensetzung mit gehalt an einer mischung von kollagen und einem antiseptischen und/oder entzuendungshemmenden wirkstoff und verfahren zu ihrer herstellung.
NO863935D0 (no) Fremgangsmaate for fremstilling av terapeutiske preparater inneholdende 2-(2-fluor-4-bifenylyl)propionsyre.
NZ191630A (en) Medicated animal feeds containing liver meal
ES2018479B3 (es) Uso de una sustancia hidrofoba para producir una preparacion enterica para el tratamiento de la obesidad, y una preparacion enterica.
ATE16394T1 (de) Stabile salze von s-adenosinylmethionin, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen welche als aktive substanz diese derivate enthalten.
DK585889D0 (da) Farmaceutisk praeparat
ATE6640T1 (de) N-benzoyl-alpha-anilinoalkylcarboxylsaeuren, deren salze und ester, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate.
BE886453A (fr) Compositions durcissables par l'oxygene comprenant un mercapto-organosiloxane, un compose fer-carbonyle et un acide
PT74119B (de) Verfahren zur herstellung von neuen estern der 7beta-<2-(2- -amino-4-thiazolyl)-2-(syn)-methoxyiminoacetamido>-3-cephem-4- -carbonsaeure und pharmazeutische praeparate die solche verbin-dungen enthalten
IE800049L (en) Hexahydro-1, 4-oxazepines
EP0127930A3 (en) Aminocyclopentane esters and their preparation and pharmaceutical formulation
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
DE68928788D1 (de) Verfahren zur Herstellung von optisch aktiven 3,4-Dihydroxybuttersäurederivaten
MX9300325A (es) (1-normon-2-il)-cetonas, procedimiento para su preparacion y composicion veterinaria o farmaceutica que las comprende.
ATE15031T1 (de) 1-(2,4-dichlorphenoxy)-3-(3,4-dimethoxy-betaphenethylamino)-2-propanol, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zusammensetzungen.
IE800960L (en) Phenylthioethyl carboxylic acid hydrazides

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970926